Skip to main content

Harnessing Stem Cell–Like T Cells to Better Fight Cancer

Better understanding the CD8+ T cells already present in tumors could be key to making immunotherapies work for more patients.

Written byDaniel E. Speiser and Werner Held
| 15 min read

Register for free to listen to this article
Listen with Speechify
0:00
15:00

ABOVE: © science source, KEITH CHAMBERS

Tumors are relatively easy to treat if they stay put, but cancer cells become more deadly when they disseminate to distant parts of the body. Surgery and local irradiation are not well suited for treating cancers that have spread and formed metastases at multiple body locations, and most types of metastatic cancer become progressively resistant to treatment with chemotherapeutic drugs or small molecule inhibitors that aim to block tumor growth.

The development of immunotherapy, a treatment that does not act directly on the tumor but rather stimulates the immune system to more effectively defend the whole body, has improved prognoses for some types of metastatic cancer. About 50 years ago, researchers found that one component of the immune system, CD8+ T cells, have the remarkable potential to detect and kill cancer cells. Groundbreaking research on melanoma, an aggressive type of skin cancer, and later ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Related Topics

Published In

July/August 2020

Life During a Pandemic

Understanding the virus is just the beginning

Related articles background image
August 2026 Digest cover
August 2026

Epic Fail: Sea-Monkeys Sabotage Fieldwork

When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.

View this Issue
Overcoming Immunotherapy Resistance in Liver Cancer

Overcoming Immunotherapy Resistance in Liver Cancer

Axion Biosystems
Optimizing NGS Library Preparation for Reliable Sequencing Data

Optimizing NGS Library Preparation for Reliable Sequencing Data

Covaris
Using TCR Repertoire Sequencing to Advance Immunology Research

Using TCR Repertoire Sequencing to Advance Immunology Research

Miltenyi
Mapping Clonal Mosaicism in Aging Tissues

Mapping Clonal Mosaicism in Aging Tissues

Mission bio

Products

Sino Biological Logo

Sino Biological Launches SuperNuclease ® Pro with Free Trial Program

Sino Biological Logo

Sino Biological Launches Precisely Characterized Full-Length p-Tau217 Protein to Advance Next-Generation Alzheimer’s Biomarker Assay Development

A photo of a scientist placing the Resipher device on a 96-well plate.

Resipher: Continuous Live-Cell Mitochondrial Respiration Monitoring in 96-Well Plates

Lucid Scientific logo
Conceptual image of ice and frost.

The VAULT100 PRO: Inside the most advanced Stirling Ultracold ULT freezer ever built.

Stirling Ultracold logo